Source: Citybizlist

Entasis: Innoviva Acquires Entasis Therapeutics

BURLINGAME, Calif.-(BUSINESS WIRE)-Innoviva, a diversified holding company with a portfolio of royalties, today announced the successful completion of its acquisition... Read More The post Innoviva Acquires Entasis Therapeutics appeared first on citybiz.

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Manos Perros's photo - President & CEO of Entasis

President & CEO

Manos Perros

CEO Approval Rating

88/100

Read more